Patient Preferences for Treatment of Basal Cell Carcinoma: Importance of Cure and Cosmetic Outcome

Authors

  • Isabelle Martin
  • Marthe-Lisa Schaarschmidt
  • Anne Glocker
  • Raphael Herr
  • Astrid Schmieder
  • Sergij Goerdt
  • Wiebke K. Peitsch

DOI:

https://doi.org/10.2340/00015555-2273

Abstract

Treatment options for localized resectable basal cell carcinoma (BCC) include micrographically controlled surgery, simple excision, curettage, laser ablation, cryosurgery, imiquimod, 5-fluorouracil, photodynamic therapy and radiotherapy. The aim of this study was to assess the preferences of patients with BCC for outcome (cure and recurrence rate, cosmetic outcome, risk of temporary and permanent complications) and process attributes (type of therapy, treatment location, anaesthesia, method of wound closure, duration of wound healing, out-of-pocket costs) of these treatments with conjoint analysis. Participants (n=124) attached greatest importance to recurrence rate (relative importance score (RIS)=17.28), followed by cosmetic outcome (RIS=16.90) and cure rate (RIS=15.02). Participants with BCC on the head or neck were particularly interested in cosmetic outcome. Those with a recurrence were willing to trade risk of recurrence, treatment location and duration of wound healing for a better cosmetic result. In summary, participants particularly valued cure and cosmetic outcome, although preferences varied with individual and tumour-associated characteristics.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2015-11-23

How to Cite

Martin, I., Schaarschmidt, M.-L., Glocker, A., Herr, R., Schmieder, A., Goerdt, S., & Peitsch, W. K. (2015). Patient Preferences for Treatment of Basal Cell Carcinoma: Importance of Cure and Cosmetic Outcome. Acta Dermato-Venereologica, 96(3), 355–360. https://doi.org/10.2340/00015555-2273

Issue

Section

Articles